Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rowe

Showing results (801-810 of 1,019) with videos related to

Pageof 102
Sort By:
Journal of Alzheimer'S Disease : JAD|August 13, 2014
Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adultsSimone Hollands, Yen Ying Lim, Rachel Buckley, et al.
Neurobiology of Aging|April 5, 2022
Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levelsAmy Woodfield, Tenielle Porter, Israa Gilani, et al.
BMC Psychiatry|October 12, 2012
Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trialElizabeth V Cyarto, Nicola T Lautenschlager, Patricia M Desmond, et al.
Archives of Neurology|July 13, 2011
In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer diseaseVictor L Villemagne, Nobuyuki Okamura, Svetlana Pejoska, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 15, 2014
Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort studyRobert H Pietrzak, J Cobb Scott, Alexander Neumeister, et al.
Neuropsychologia|March 18, 2008
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's diseaseV L Villemagne, K E Pike, D Darby, et al.
Journal of Neuroimmunology|June 9, 2014
An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulationAlan Rembach, Andrew D Watt, William J Wilson, et al.
Journal of Molecular Neuroscience : MN|September 3, 2016
Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild DementiaYen Ying Lim, Victor L Villemagne, Simon M Laws, et al.
Research Square|May 18, 2026
Genetic variation in the glymphatic pathway predicts cognition and neurodegeneration in preclinical Alzheimer's diseaseAyeisha Milligan Armstrong, Eleanor K O'Brien, Shane M Fernandez, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 28, 2014
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome studyKevin T Ong, Victor L Villemagne, Alex Bahar-Fuchs, et al.
Pageof 102

Showing results (801-810 of 1,019) with videos related to

Sort By:
Pageof 102
Journal of Alzheimer'S Disease : JAD|August 13, 2014
Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adultsSimone Hollands, Yen Ying Lim, Rachel Buckley, et al.
Neurobiology of Aging|April 5, 2022
Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levelsAmy Woodfield, Tenielle Porter, Israa Gilani, et al.
BMC Psychiatry|October 12, 2012
Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trialElizabeth V Cyarto, Nicola T Lautenschlager, Patricia M Desmond, et al.
Archives of Neurology|July 13, 2011
In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer diseaseVictor L Villemagne, Nobuyuki Okamura, Svetlana Pejoska, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 15, 2014
Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort studyRobert H Pietrzak, J Cobb Scott, Alexander Neumeister, et al.
Neuropsychologia|March 18, 2008
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's diseaseV L Villemagne, K E Pike, D Darby, et al.
Journal of Neuroimmunology|June 9, 2014
An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulationAlan Rembach, Andrew D Watt, William J Wilson, et al.
Journal of Molecular Neuroscience : MN|September 3, 2016
Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild DementiaYen Ying Lim, Victor L Villemagne, Simon M Laws, et al.
Research Square|May 18, 2026
Genetic variation in the glymphatic pathway predicts cognition and neurodegeneration in preclinical Alzheimer's diseaseAyeisha Milligan Armstrong, Eleanor K O'Brien, Shane M Fernandez, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 28, 2014
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome studyKevin T Ong, Victor L Villemagne, Alex Bahar-Fuchs, et al.
Pageof 102